Sypharma
Dandenong, Australia· Est.
Australian GMP‑accredited contract manufacturer delivering end‑to‑end production for therapeutic, veterinary and consumer health products.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
Australian GMP‑accredited contract manufacturer delivering end‑to‑end production for therapeutic, veterinary and consumer health products.
Therapeutic GoodsVeterinaryConsumer Health
Technology Platform
GMP‑compliant manufacturing with Class A/B aseptic filling, Class C terminal sterilisation, and integrated analytical testing (NIR, HPLC) under TGA, FDA, ISO13485 and APVMA approvals.
Opportunities
Increasing demand for GMP‑accredited contract manufacturing of mRNA vaccines, biologics and specialty consumer health products offers scalable growth.
Risk Factors
Regulatory compliance pressures, capacity constraints, and competition from larger multinational CMOs could limit market share expansion.
Competitive Landscape
Competes with global CMOs such as Patheon, Catalent and Lonza; differentiates through Australian regulatory approvals and integrated veterinary/consumer product capabilities.